Q: With the Horizon announcement that there are 2 (named) possible acquirers (by Jan.23/23), would you wait or, after the recent jump, take the money and run?
Q: Hznp multiples seem reasonable. Is the big share price due to concerns over a big facilities expansion in a new geography (capex)? What's you take please?
Q: How do you see the U. S. Build Back Better bill (where the gov't will have more price negotiating power with pharmas) affecting the industry. Is Horizon, with it's rare disease drugs, more vulnerable than most?